Cargando…
Biliary tract large cell neuroendocrine carcinoma: current evidence
BACKGROUND: Primary neuroendocrine carcinomas of the gallbladder and biliary tract are rare, with pure large cell neuroendocrine carcinomas (LCNEC) being exceedingly rare and with a particularly poor prognosis. METHODS: We performed a review of published data on biliary tract large cell neuroendocri...
Autores principales: | Raiker, Riva, Chauhan, Aman, Hasanein, Hassan, Burkeen, Grant, Horn, Millicent, Veedu, Janeesh, Vela, Cory, Arnold, Susanne, Kolesar, Jill, Anthony, Lowell, Evers, B. Mark, Cavnar, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6869278/ https://www.ncbi.nlm.nih.gov/pubmed/31752927 http://dx.doi.org/10.1186/s13023-019-1230-2 |
Ejemplares similares
-
Gynecologic large cell neuroendocrine carcinoma: A review
por: Burkeen, Grant, et al.
Publicado: (2020) -
Immune checkpoint inhibitors in large cell neuroendocrine carcinoma: current status
por: Chauhan, Aman, et al.
Publicado: (2018) -
Immune checkpoint inhibitors in neuroendocrine tumors: A single institution experience with review of literature
por: Chauhan, Aman, et al.
Publicado: (2017) -
hPG(80) (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors
por: Chauhan, Aman, et al.
Publicado: (2022) -
Post FDA approval analysis of 200 gallium-68 DOTATATE imaging: A retrospective analysis in neuroendocrine tumor patients
por: Chauhan, Aman, et al.
Publicado: (2020)